Biotricity, Inc. - BTCY

SEC FilingsOur BTCY Tweets

About Gravity Analytica

Recent News

  • 04.24.2026 - Why Continuous Cardiac Monitoring with Mobile Cardiac Telemetry Is Replacing Traditional Holter Testing
  • 04.24.2026 - Discover The Top Trends Shaping Digital Cardiology
  • 04.22.2026 - How Early Detection Through Wearable Heart Monitoring Saves Lives
  • 04.22.2026 - From Devices to Platforms: The Shift Toward Integrated Digital Healthcare Ecosystems
  • 04.22.2026 - The Future of Wearable Health Technology in Chronic Disease Management
  • 04.22.2026 - How Remote Cardiac Monitoring is Expected to Evolve in the Next Decade
  • 12.03.2025 - Understanding EKG Heart Rhythms and What They Reveal About Your Health
  • 12.03.2025 - Beyond the Beat: How Biotricity’s Biocore Pro Outperforms Other Heart Monitors
  • 12.03.2025 - How Biotricity Is Transforming the Future of Cardiovascular Tests
  • 12.03.2025 - Why Biotricity Leads the Heart Monitoring Revolution: Smarter, Faster, and More Reliable Than the Rest

Recent Filings

  • 02.18.2026 - EX-99.1 EX-99.1
  • 02.18.2026 - 8-K Current report
  • 02.11.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 02.04.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 12.19.2025 - S-1 General form for registration of securities under the Securities Act of 1933
  • 11.18.2025 - 8-K Current report
  • 11.18.2025 - EX-99.1 EX-99.1
  • 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]